These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8208540

  • 1. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.
    Zhang J, Chang CC, Lombardi L, Dalla-Favera R.
    Oncogene; 1994 Jul; 9(7):1931-7. PubMed ID: 8208540
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC, Zhang J, Lombardi L, Neri A, Dalla-Favera R.
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
    Kim KE, Gu C, Thakur S, Vieira E, Lin JC, Rabson AB.
    Oncogene; 2000 Mar 02; 19(10):1334-45. PubMed ID: 10713675
    [Abstract] [Full Text] [Related]

  • 4. The generation of nfkb2 p52: mechanism and efficiency.
    Heusch M, Lin L, Geleziunas R, Greene WC.
    Oncogene; 1999 Nov 04; 18(46):6201-8. PubMed ID: 10597218
    [Abstract] [Full Text] [Related]

  • 5. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
    Fracchiolla NS, Lombardi L, Salina M, Migliazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo AT, Neri A.
    Oncogene; 1993 Oct 04; 8(10):2839-45. PubMed ID: 8378093
    [Abstract] [Full Text] [Related]

  • 6. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.
    Neri A, Fracchiolla NS, Migliazza A, Trecca D, Lombardi L.
    Leuk Lymphoma; 1996 Sep 04; 23(1-2):43-8. PubMed ID: 9021684
    [Abstract] [Full Text] [Related]

  • 7. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
    Dobrzanski P, Ryseck RP, Bravo R.
    Oncogene; 1995 Mar 02; 10(5):1003-7. PubMed ID: 7898917
    [Abstract] [Full Text] [Related]

  • 8. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway.
    Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM, Gilmore TD.
    Oncogene; 2002 Dec 12; 21(57):8759-68. PubMed ID: 12483529
    [Abstract] [Full Text] [Related]

  • 9. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.
    Chang CC, Zhang J, Lombardi L, Neri A, Dalla-Favera R.
    Mol Cell Biol; 1995 Sep 12; 15(9):5180-7. PubMed ID: 7651435
    [Abstract] [Full Text] [Related]

  • 10. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
    Cressman DE, Taub R.
    Oncogene; 1993 Sep 12; 8(9):2567-73. PubMed ID: 8361766
    [Abstract] [Full Text] [Related]

  • 11. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS.
    Oncogene; 2000 Feb 24; 19(9):1123-31. PubMed ID: 10713699
    [Abstract] [Full Text] [Related]

  • 12. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
    Grumont RJ, Richardson IB, Gaff C, Gerondakis S.
    Cell Growth Differ; 1993 Sep 24; 4(9):731-43. PubMed ID: 8241021
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.
    Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang CC, Antonacci R, Fracchiolla NS, Ciana P, Maiolo AT, Neri A.
    Blood; 1994 Dec 01; 84(11):3850-60. PubMed ID: 7949142
    [Abstract] [Full Text] [Related]

  • 14. Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.
    Ciana P, Neri A, Cappellini C, Cavallo F, Pomati M, Chang CC, Maiolo AT, Lombardi L.
    Oncogene; 1997 Apr 17; 14(15):1805-10. PubMed ID: 9150386
    [Abstract] [Full Text] [Related]

  • 15. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
    Dejardin E, Bonizzi G, Bellahcène A, Castronovo V, Merville MP, Bours V.
    Oncogene; 1995 Nov 02; 11(9):1835-41. PubMed ID: 7478612
    [Abstract] [Full Text] [Related]

  • 16. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D, Rizzo CA, Dorfman K, Bravo R.
    EMBO J; 1996 Jul 15; 15(14):3640-50. PubMed ID: 8670867
    [Abstract] [Full Text] [Related]

  • 17. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
    Kleinert H, Euchenhofer C, Ihrig-Biedert I, Förstermann U.
    Mol Pharmacol; 1996 Jan 15; 49(1):15-21. PubMed ID: 8569701
    [Abstract] [Full Text] [Related]

  • 18. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
    Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ.
    Clin Cancer Res; 1999 Jan 15; 5(1):119-27. PubMed ID: 9918209
    [Abstract] [Full Text] [Related]

  • 19. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC, Kazandjian D, Harkness DD, Petros S, Dave J, White DW, Gilmore TD.
    Oncogene; 2000 Feb 03; 19(5):599-607. PubMed ID: 10698504
    [Abstract] [Full Text] [Related]

  • 20. Role of p52 (NF-kappaB2) in LPS tolerance in a human B cell line.
    Wedel A, Frankenberger M, Sulski G, Petersmann I, Kuprash D, Nedospasov S, Ziegler-Heitbrock HW.
    Biol Chem; 1999 Oct 03; 380(10):1193-9. PubMed ID: 10595582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.